Ilsung Pharm Long-term Investment Intensity
Ilsung Pharm long-term investment intensity. Ilsung Pharm (003120) has a Long-term Investment Intensity of 18.7% as of December 2019. Long-term investments of ₩69.18 Billion represent 18.7% of total assets of ₩369.52 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Ilsung Pharm balance sheet liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Ilsung Pharm (2013–2019)
Long-term investment intensity of Ilsung Pharm from 2013 to 2019. This chart shows how Ilsung Pharm's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 18.7%, reflecting long-term investments of ₩69.18 Billion against total assets of ₩369.52 Billion KRW.
Ilsung Pharm Long-term Investment Intensity by Year (2013–2019)
Ilsung Pharm long-term investment intensity by year from 2013 to 2019. The table below presents the year-by-year Long-term Investment Intensity for Ilsung Pharm from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 003120 current and non-current assets.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 18.7% | ₩69.18 Billion | ₩369.52 Billion | ▲ +7.7 pp |
| 2018 | 11.0% | ₩38.35 Billion | ₩347.26 Billion | ▼ -0.7 pp |
| 2017 | 11.7% | ₩40.80 Billion | ₩347.46 Billion | ▲ +0.2 pp |
| 2016 | 11.6% | ₩39.14 Billion | ₩338.50 Billion | ▲ +1.8 pp |
| 2015 | 9.7% | ₩35.71 Billion | ₩367.03 Billion | ▼ -44.7 pp |
| 2014 | 54.5% | ₩206.06 Billion | ₩378.37 Billion | ▲ +0.0 pp |
| 2013 | 54.5% | ₩202.93 Billion | ₩372.66 Billion | — |